University of Louisville homepage
All experts
All experts

Hiram Rivas Perez

Professor Term

School of Medicine

Orcid identifier0009-0001-9446-2278
  • Professor Term
    School of Medicine

SPONSORED PROJECTS

Chronic fibrosing interstitial lung disease

COPD

Lung cancer

SPONSORED PROJECTS

  • Showing page 1 out of 1
Showing page 1, sponsored projects 1 to 15 of 15
GRANT
240451|AR-DEX-22-03 - A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of Dexpramipexole Administered Orally for 24 Weeks in Participants with Eosinophilic Asthma (EXHALE-4)
Worldwide Clinical Trials Inc_WCT1 Jan 2024
MORELEARN MORE
GRANT
240505|AR-DEX-22-02 - A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy, safety, and tolerability of dexpramipexole administered orally for 52 weeks in participants with severe eosinophilic asthma (EXHALE-3)
Worldwide Clinical Trials Inc_WCT1 Jan 2024
MORELEARN MORE
GRANT
230873|CMTX101-P1-CT001 - A 2 Part First-in-Human Study to Evaluate the Safety, Tol Pharmacokinetics, and Immunogenicity of CMTX-101, an Anti DNABII Monoclonal Antibody, in Healthy Subjects (Part 1) and Hospitalized Subjects with Suspected or Confirmed ...
Medpace Inc_MPI8 Jul 2023
MORELEARN MORE
GRANT
240054|GB44332 -A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Astegolimab in Patients with Chronic Obstructive Pulmonary Disease
PPD Clinical Research_PCR9 Jun 2023
MORELEARN MORE
GRANT
210766|CS006 - A Clinical Evaluation of the RheOx Bronchial Rheoplasty System for the Treatment of the Symptoms of Chronic Bronchitis in Adult Patients with COPD
Gala Therapeutics Inc_GTINC5 May 2021
MORELEARN MORE
GRANT
220148|RCC-2116 - Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP)
Global Coalition for Adaptive Res_GCFAR1 Jan 2021
MORELEARN MORE
GRANT
200112|FGCL-3019-091"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects with Idiopathic Pulmonary Fibrosis (IPF)" ("Protocol"), Protocol number
Worldwide Clinical Trials Inc_WCT1 Jun 2020
MORELEARN MORE
GRANT
200613|D0543 A Multicenter, Randomized Sham-Controlled Study to Evaluate Safety and Efficacy After Treatment with the Nuvaira Lung Denervation System in Patients with Chronic Obstructive Pulmonary Disease (COPD) (AIRFLOW-3)
Nuvaira Inc_NUVAIRA4 Jan 2020 - 31 Dec 2026
MORELEARN MORE
GRANT
210104|GC2007-A Multicenter, Randomized, Open-Label Parallel Group Pilot Study to Evaluate Safety and Efficacy of High Dose IVIG plus SMT vs SMT alone in Subjects with Covid-19 Requiring Admission to the Intensive Care Unit
Clinical Trial Services Inc_CTSI1 Jan 2020
MORELEARN MORE
GRANT
210198|Medication Use Evaluation Study with GIAPREZA for Patients with Septic Shock due to COVID-19
La Jolla Pharmaceutical1 Jan 2020
MORELEARN MORE
GRANT
200194|ATYR1923-C-002 A Randomized, Double-Blind, Placebo-Controlled Multiple Ascending Dose Study of Intravenous ATYR1923 in Patients with Pulmonary Sarcoidosisa
aTyr Pharma Inc_ATYRI1 Jan 2019
MORELEARN MORE
GRANT
180762|BPS-314d-MR-PAH-303 An Open-Label Extension of BPS-314d-MR-PAH-302 in Pulmonary Artierial Hypertension Patients
Lung Rx LLC_LUNGRX1 Jan 2018
MORELEARN MORE
GRANT
171086|TDE-HF-301 A Multicenter,Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in subjects with Pulmonary Hypertension (PH) in Heart Failure with Preserved Ejection Fraction (HFpEF)
United Therapeutics Corporation_UTC1 Jan 2017
MORELEARN MORE
GRANT
130891|Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) and Chronic Fibrosing Intersitial Lung Disease with Progressive Phenotype Prospective Outcomes (ILD-PRO) Registry
Duke Clinical Research Institute_DCRI5 Jan 2014 - 31 Dec 2024
MORELEARN MORE
GRANT
130169|630-0012-A, Lung Function Improvement after Bronchoscopic Lung Volume Reduction with Pulmonx Endobronchial Valves used in Treatment of Emphysema - LIBERATE Study
Pulmonx_PUL4 Jan 2013 - 31 Dec 2022
MORELEARN MORE